港股異動 | 蒙牛乳業(2319.HK)午後拉昇5.34% 大家機構唱多
格隆匯10月20日丨蒙牛乳業(2319.HK)午後拉昇5.34%,報39.45港元,總市值1557億港元。瑞銀最新研報上調對蒙牛乳業投資評級,由“中性”升至“買入”,上調目標價由30港元升至44港元,此按綜合方式作估值,相當預測2021年及2022年市盈率各29倍及25倍。該行升蒙牛於2020年至2022年純利預測各11%、10%及10%。此外,蒙牛乳業也獲凱基上調目標價,由33.3港元調整至47.68港元,投資評級由中性調整至跑贏大市。10月15日,鵬元國際信評首次授予中國蒙牛乳業有限公司(蒙牛)'BBB+'的國際刻度長期主體評級,展望為穩定。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.